July 18, 2011
MESSAGE FROM THE DIRECTOR
Report from the AACI-NCI Working Group on Clinical Trials Reporting (CRTP)
The NCI and AACI have worked over the past year to develop clinical trials reporting guidelines that are aligned with the IOM report on cancer clinical trials and provide NCI with a uniform database. The key elements of these guidelines include a uniform procedure for classification of protocols, a time line for reporting implementation, and a time line for reporting accrual information. The new guidelines will also result in audits of both protocol reporting and accrual reporting.
We will comply with these new regulations through our Clinical Trials Office, directed by Katarzyna Karelus. Kat will be happy to answer any questions you have, and may be reached at email@example.com. This process will also assist us in appreciating the publicly available database when we design investigator initiated or national trials. Please review the recently released CRTP report, which can be found on the NCI website.
CASE CCC IN THE NEWS
In Addition to Hospitals, Community at Large Must Address Health Care Disparities
New Cancers in the Family May Merit Extra Screening
Lyndhurst Couple Gives $17 Million to UH Rainbow for New Adolescent & Young Adult Cancer Institute
A Closer Look at Barrett's Esophagus: NetWellness
Men More Likely Than Women to Die of Cancer
Multilevel Interventions in Health Care
There is a playlist on the NIH YouTube channel featuring presentations, keynote addresses, and Q&A sessions from the March 2011 Multilevel Interventions in Health Care conference. In addition, researchers are encouraged to explore two resources for continuing the conversation about multilevel intervention research. First, check out the recent blog post The Potential of Multilevel Interventions to Improve Health IT on the Informatics for Consumer Health Web site and add your comments. Second, join the new LinkedIn Group Multilevel Interventions in Health Care. Use the group's features to share interesting news and articles relevant multilevel interventions or to exchange ideas about this research area. The group will also be the channel for announcements about the NCI's Multilevel Interventions project, including news about the upcoming JNCI supplement.
Newly Improved Office of Rare Diseases Research (ORDR) Biospecimens/Biorepositories Web site
The NIH Office of Rare Diseases Research (ORDR) has released a newly improved Biospecimens/Biorepositories web site, Rare Disease-HUB (RD-HUB). The purpose of this site is to have a portal for the researchers to locate and inquire on the availability of specimens from the different existing biorepositories around the globe. For the repositories who are interested in sharing their inventory, this site can serve them well by letting researchers check whether the specimens with the specific requirements they are looking for is available, before contacting the repository. The goal of RD-HUB is to serve the global research community, the patients and the patient advocacy groups and the large community as well.
Although the site will continue to include common diseases such as cancer and other diseases, the focus of the RD-HUB will be on rare diseases. All rare diseases (about 7,000) are now included. In addition to assisting researchers locate specimens, the scope of the RD-HUB includes providing links to best practices for specimen collection, handling, and processing; models and templates for informed consent, and ethical and legal guidelines for handling human subject material for research and treatment; as well as links to related articles and protocols and other useful information.
Clinical Research Scholar Career Development Training Opportunity
The CTSC KL2 seeks outstanding candidates to fill Clinical Research (CR) Scholar positions available in July 2012. The training program is funded by the NIH and it is a component of the Cleveland Clinical and Translational Science Collaborative. This innovative program is a collaboration involving CWRU, Cleveland Clinic, UH and MetroHealth. Each CR Scholar will embark on a 4-year program of intensive training in interdisciplinary team-based, patient-oriented research, combining a novel educational program with mentored research experiences.
Interested applicants are encouraged to attend upcoming informational sessions. To make a reservation, please contact contact Beth Spyke, MPA at firstname.lastname@example.org or 216-444-2702. Applications will be accepted through October 10.
Many researchers in the Case CCC utilize core services for array-based genomics studies and next generation sequencing studies. These data can be challenging to work with, and the Cancer Center is planning on implementing a new core facility, the Bioinformatics Analysis Core, to assist with these services.
Induced Pluripotent Stem Cell Pilot Research Award
The Pluripotent Stem Cell Facility (PSCF) seeks to support the creation of up to eight disease–specific iPS cell lines in 2011. Investigators will provide a patient fibroblast sample which the PSCF will reprogram into an iPS cell line for study in the investigator's laboratory. Funding for the creation of these cell lines is provided by a CWRU Interdisciplinary Alliance Investment Grant (IAIG) with contributions from the Provost, the School of Medicine, the Case School of Engineering, and the College of Arts and Sciences, as well as Cleveland Clinic and NCRM. It is expected that the creation of these disease–specific iPS cell lines will provide investigators with the preliminary data needed to apply for NIH or equivalent funding. All CWRU and Cleveland Clinic faculty members are encouraged to apply.
Deadline: August 31
AACR Award for Lifetime Achievement in Cancer Research
The AACR Award for Lifetime Achievement in Cancer Research was established and first given in 2004 to honor an individual who has made significant fundamental contributions to cancer research, either through a single scientific discovery or a body of work. These contributions, whether they have been in research, leadership, or mentorship, must have had a lasting impact on the cancer field and must have demonstrated a lifetime commitment to progress against cancer.
Deadline: September 26
AACR-Women in Cancer Research Charlotte Friend Memorial Lectureship
The AACR-Women in Cancer Research Charlotte Friend Memorial Lectureship was established in 1998 in honor of renowned virologist and discoverer of the Friend virus, Dr. Charlotte Friend, for her pioneering research on viruses, cell differentiation and cancer. The lecture is intended to give recognition to an outstanding female or male scientist who has made meritorious contributions to the field of cancer research and who has, through leadership or by example, furthered the advancement of women in science. Candidacy is open to all cancer researchers who are affiliated with any institution involved in cancer research, cancer medicine or cancer-related biomedical science anywhere in the world.
Deadline: October 11
AACR G.H.A. Clowes Memorial Award
AACR and Eli Lilly and Company established this award in 1961 to honor Dr. G.H.A. Clowes, who was a founding member of the AACR and a research director of Eli Lilly. The Clowes Award recognizes an individual with outstanding recent accomplishments in basic cancer research. Candidacy is open to all cancer researchers who are affiliated with any institution involved in cancer research, cancer medicine or cancer-related biomedical science anywhere in the world.
Deadline: October 11
AACR-Minorities in Cancer Research Jane Cooke Wright Lectureship
The AACR-Minorities in Cancer Research Jane Cooke Wright Lectureship is intended to give recognition to an outstanding scientist who has made meritorious contributions to the field of cancer research and who has, through leadership or by example, furthered the advancement of minority investigators in cancer research. Candidacy is open to all cancer researchers who are affiliated with any institution involved in cancer research, cancer medicine or cancer-related biomedical science anywhere in the world.
Nomination Deadline: October 11
AACR Award for Outstanding Achievement in Cancer Research
Through the generous contribution of an anonymous donor, AACR established this award in 1979 to give recognition to a young investigator on the basis of meritorious achievement in cancer research. In accordance with the wishes of the donor, the recipient must be no more than 40 years of age by the time the award is received. Candidacy is open to all cancer researchers who are affiliated with any institution involved in cancer research, cancer medicine or cancer-related biomedical science anywhere in the world.
Deadline: October 11
Case CCC Clinical Trials Funding Opportunity
The Case Comprehensive Cancer Center is announcing the availability of Protocol Specific Research Support (PSRS) funding for Year 2011. The budgeted funds are for the conduct of early phase clinical trial and restricted to support research nurses and data managers directly involved in the conduct of these clinical trials. Studies developed jointly between UH and CCF with planned accrual at both institutions will be prioritized. Please direct questions and requests for information about the funding process to Katarzyna Karelus, Administrative Director, Case Comprehensive Cancer Center Clinical Research Office, at (216) 368-6287 or email@example.com.
NCI CANCER BULLETIN
**All events are open to anyone interested in attending
Special Presentation: Hematology and Oncology Research Conference
Stem Cells Biology and Regenerative Medicine Seminar
Cancer Center Research in Progress Seminar will resume September 2.
Hematology/Oncology Fellows Curriculum Series
Hematology/Oncology Fellows Curriculum Series
UPCOMING CANCER CENTER SYMPOSIUMS & EVENTS
Olof Pearson Lecture
Imaging Solutions in Cancer Management: A Case-based Conference
ADDITIONAL UPCOMING SEMINARS & EVENTS
MSC 2011: Innovations in Cell-Based Regenerative Therapies
First Ascoli Piceno Conference on Gene Vaccination in Cancer
8th International Conference of the Society for Integrative Oncology: Innovating Integrative Oncology: New Science, New Solutions
PREVIOUSLY ANNOUNCED FUNDING OPPORTUNITIES
2012 Searle Scholar Program
Uniting Against Lung Cancer 2011 Legacy Program for Advances in Lung Cancer Research
NIH BULLETIN – Notices and Funding Opportunities
Gillian Irwin Todd
11100 Euclid Avenue, Wearn 149
Cleveland, Ohio 44106-5065
HELP US HELP YOU!
If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades!
Send items to firstname.lastname@example.org.